HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam J Singer Selected Research

Necrosis

9/2021Development of a porcine hard-to-heal wound model: evaluation of a bromelain-based enzymatic debriding agent.
1/2018Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
10/2015The Role of Necroptosis in Burn Injury Progression in a Rat Comb Burn Model.
7/2013Endothelial necrosis at 1 hour postburn predicts progression of tissue injury.
11/2012Histopathologic staining of low temperature cutaneous burns: comparing biomarkers of epithelial and vascular injury reveals utility of HMGB1 and hematoxylin phloxine saffron.
9/2011Spatiotemporal progression of cell death in the zone of ischemia surrounding burns.
1/2011Curcumin reduces injury progression in a rat comb burn model.
5/2009Rosiglitazone, a PPAR-gamma ligand, reduces burn progression in rats.
3/2009Validation of a porcine comb burn model.
6/2008Apoptosis and necrosis in the ischemic zone adjacent to third degree burns.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam J Singer Research Topics

Disease

63Burns
12/2023 - 10/2002
50Wounds and Injuries (Trauma)
12/2023 - 03/2002
18Cicatrix (Scar)
12/2023 - 03/2002
17Pain (Aches)
06/2019 - 06/2004
13Myocardial Infarction
11/2023 - 01/2011
13Necrosis
09/2021 - 12/2005
11Heart Failure
12/2022 - 01/2008
11Lacerations
01/2020 - 03/2002
9Hemorrhage
09/2023 - 09/2003
9Acute Coronary Syndrome
12/2022 - 07/2008
9Ischemia
01/2018 - 12/2007
8Infections
01/2021 - 08/2002
7Chest Pain (Chest Pains)
11/2023 - 06/2005
6Venous Thromboembolism
01/2021 - 05/2010
5COVID-19
10/2022 - 01/2020
4Inflammation (Inflammations)
05/2022 - 11/2008
4ST Elevation Myocardial Infarction
12/2021 - 11/2007
4Pulmonary Embolism
01/2018 - 05/2010
4Vomiting
01/2017 - 04/2009
4Hypothermia
09/2014 - 06/2006
3Sepsis (Septicemia)
12/2023 - 08/2014
3Chronic Obstructive Pulmonary Disease (COPD)
11/2021 - 01/2008
3Hyperkalemia
10/2020 - 09/2017
3Musculoskeletal Pain
01/2019 - 12/2004
3Atrial Fibrillation
05/2017 - 10/2011
3Nausea
01/2017 - 04/2009
3Heart Arrest (Cardiac Arrest)
07/2016 - 11/2009
3Appendicitis
01/2016 - 02/2007
3Thrombosis (Thrombus)
01/2016 - 10/2002
3Surgical Wound
12/2007 - 03/2002
2Asthma (Bronchial Asthma)
11/2021 - 11/2008
2Abdominal Pain (Pain, Abdominal)
10/2021 - 02/2007
2Respiratory Insufficiency (Respiratory Failure)
10/2021 - 09/2003

Drug/Important Bio-Agent (IBA)

19Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2005
13brassIBA
11/2020 - 12/2007
12Troponin IIBA
12/2021 - 06/2005
12Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 12/2007
12Hematoxylin (Haematoxylon)IBA
01/2018 - 12/2007
10TroponinIBA
11/2023 - 01/2011
10AluminumIBA
01/2020 - 10/2002
9Analgesics (Analgesic Drugs)IBA
01/2023 - 11/2004
8Bromelains (Bromelain)IBA
12/2023 - 12/2004
7Opioid Analgesics (Opioids)IBA
01/2023 - 12/2004
7octylcyanoacrylateIBA
10/2011 - 03/2002
6Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2008
6Tissue Adhesives (Tissue Adhesive)IBA
07/2006 - 08/2002
5Warfarin (Coumadin)FDA LinkGeneric
06/2021 - 01/2016
5Ointments (Pastes)IBA
11/2020 - 09/2010
5theasinensin AIBA
01/2020 - 12/2008
5CollagenIBA
11/2012 - 10/2002
5Brain Natriuretic Peptide (Natrecor)FDA Link
12/2011 - 06/2007
5Lidocaine (Xylocaine)FDA LinkGeneric
07/2008 - 06/2004
4tyramine-deoxysorbitolIBA
02/2023 - 01/2022
4fibrin fragment D (D-dimer)IBA
01/2021 - 05/2010
4MetalsIBA
11/2020 - 03/2010
4AnticoagulantsIBA
01/2017 - 01/2016
4Dihydrotachysterol (AT 10)IBA
03/2012 - 03/2002
4Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2012 - 10/2002
3Troponin T (Troponin T1)IBA
11/2023 - 03/2021
3ElectrolytesIBA
06/2023 - 07/2008
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 12/2007
3PotassiumIBA
10/2020 - 09/2017
3Fibrinogen (Factor I)FDA Link
02/2020 - 01/2016
3RivaroxabanIBA
01/2018 - 01/2016
3Peptides (Polypeptides)IBA
01/2018 - 10/2008
3AntiemeticsIBA
01/2017 - 04/2009
3Petrolatum (Vaseline)FDA Link
08/2015 - 09/2010
3Coloring Agents (Dyes)IBA
08/2015 - 11/2012
3IceIBA
09/2014 - 01/2010
3Saline SolutionIBA
09/2014 - 01/2006
3Peroxidase (Myeloperoxidase)IBA
09/2013 - 03/2013
3octyl 2-cyanoacrylateIBA
11/2012 - 05/2004
3CurcuminIBA
08/2011 - 12/2007
3CyanoacrylatesIBA
05/2010 - 05/2008
3salicylhydroxamic acid (SHAM)IBA
06/2006 - 09/2005
2Peptide Hydrolases (Proteases)FDA Link
12/2023 - 12/2004
2trans-crotonin (CTN)IBA
11/2023 - 01/2021
2Factor Xa InhibitorsIBA
09/2023 - 01/2016
2Collagenases (Collagenase)FDA Link
01/2023 - 09/2021
2Bronchodilator Agents (Bronchodilators)IBA
11/2021 - 01/2008
2Vitamin KFDA Link
06/2021 - 01/2017
2Insulin (Novolin)FDA Link
10/2020 - 12/2018
2Tadalafil (Cialis)FDA Link
01/2020 - 01/2018
2Phosphodiesterase 5 InhibitorsIBA
01/2020 - 01/2018

Therapy/Procedure

23Therapeutics
10/2022 - 11/2002
12Debridement
12/2023 - 12/2004
11Length of Stay
12/2023 - 06/2005
9Sutures (Suture)
01/2020 - 03/2002
5Artificial Respiration (Mechanical Ventilation)
10/2022 - 01/2008
5Lasers (Laser)
08/2015 - 09/2005
4Percutaneous Coronary Intervention
12/2021 - 11/2007
4Analgesia
01/2016 - 11/2004
4Aftercare (After-Treatment)
07/2014 - 10/2009
3Autologous Transplantation
09/2023 - 05/2014
3Critical Care (Surgical Intensive Care)
11/2022 - 12/2009
3Mechanical Ventilators (Ventilator)
10/2022 - 07/2009
3Occlusive Dressings (Occlusive Dressing)
08/2015 - 05/2003
3Anesthesia
10/2006 - 09/2005
3Contraindications
09/2005 - 06/2004
2Ambulatory Care (Outpatient Care)
01/2021 - 01/2018